Hypothesis

We propose that aging is governed by a bistable signaling module in which mTORC1 activity and epigenetic entropy reciprocally reinforce each other, creating two stable states: a youthful, low‑entropy configuration and an aged, high‑entropy configuration. The transition between these states is not a gradual drift but a switch‑like transition triggered when cumulative damage pushes the system past a critical threshold.

Mechanistic Basis

• mTORC1 integrates nutrient signals and directly influences protein synthesis, autophagy, and mitochondrial function {1}.
• Persistent mTORC1 activation promotes chromatin relaxation and histone acetylation, increasing epigenetic noise {2}.
• Elevated epigenetic noise impairs the feedback inhibition of mTORC1 (e.g., via reduced expression of TSC2 or AMPK subunits), further amplifying mTORC1 signaling {3}.
• This positive feedback creates a bistable system where modest fluctuations are damped in the youthful state but once epigenetic entropy exceeds a set point, the system flips to a self‑sustaining aged state that is resistant to rapamycin or caloric restriction unless the epigenetic landscape is reset.

Testable Predictions

1. Bimodal distribution – In genetically identical mice of intermediate age, single‑cell measurements of phospho‑S6 (mTORC1 readout) and histone H3K27ac variance will show two distinct clusters rather than a continuous gradient.
2. Hysteresis – Transient rapamycin treatment will revert cells from the aged cluster to the youthful cluster only if administered before the epigenetic noise crosses a quantifiable threshold; after threshold crossing, the same treatment will fail to revert the state.
3. Switch reset – Targeted epigenetic editing (e.g., CRISPR‑dCas9‑TET1 to reduce DNA methylation at mTORC1‑responsive promoters) will lower the threshold for mTORC1 inhibition, allowing rapamycin to re‑induce the youthful state even in older animals.
4. Metabolic clock coupling – The feeding‑entrained mTORC1 oscillator will exhibit altered amplitude and period in the aged state, measurable via live‑reporters of lysosomal activity in vivo.

Potential Experiments

• Single‑cell multimodal profiling (phospho‑proteomics + scATAC‑seq) on liver and muscle from mice aged 6, 12, and 18 months to identify the predicted bimodal clusters.
• Drug wash‑out assays: treat 12‑month‑old mice with rapamycin for 2 weeks, withdraw, and track mTORC1 activity and epigenetic marks over time to detect hysteresis.
• Epigenetic rescue: AAV‑delivered dCas9‑TET1 to the promoters of Ragulator subunits in 18‑month‑old mice, followed by rapamycin treatment, assess frailty indices and tissue function.
• Real‑time mTORC1 reporter (e.g., mTORC1‑KTR) implanted in subcutaneous tissue, combined with continuous glucose monitoring, to quantify oscillator changes across the predicted transition.

If these experiments confirm the existence of a bistable mTORC1‑epigenetic switch, it would reframe aging as a phase transition rather than a linear accumulation of damage, suggesting that interventions must target both signaling and epigenetic layers to reverse the aged state.

}